Enhancing Endogenous Hyaluronic Acid in Osteoarthritic Joints with an Anti‐Inflammatory Supramolecular Nanofiber Hydrogel Delivering HAS2 Lentivirus
Small · 2024
DOI: 10.1002/smll.202400542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Feng Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, The First Affiliated Hospital, Medical 3D Printing Center, Orthopedic Institute, School of Biology & Basic Medical…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Nanofibers, Hydrogels, Lentivirus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Gusu Health Talent Project of Suzhou City.
Abstract (Originalsprache)
Osteoarthritis (OA) management remains challenging because of its intricate pathogenesis. Intra‐articular injections of drugs, such as glucocorticoids and hyaluronic acid (HA), have certain limitations, including the risk of joint infection, pain, and swelling. Hydrogel‐based therapeutic strategies have attracted considerable attention because of their enormous therapeutic potential. Herein, a supramolecular nanofiber hydrogel is developed using dexamethasone sodium phosphate (DexP) as a vector to deliver lentivirus‐encoding hyaluronan synthase 2 (HAS2) (HAS2@DexP‐Gel). During hydrogel degradation, HAS2 lentivirus and DexP molecules are slowly released. Intra‐articular injection of HAS2@DexP‐Gel promotes endogenous HA production and suppresses synovial inflammation. Additionally, HAS2@DexP‐Gel reduces subchondral bone resorption in the anterior cruciate ligament transection‐induced OA mice, attenuates cartilage degeneration, and delays OA progression. HAS2@DexP‐Gel exhibited good biocompatibility both in vitro and in vivo. The therapeutic mechanisms of the HAS2@DexP‐Gel are investigated using single‐cell RNA sequencing. HAS2@DexP‐Gel optimizes the microenvironment of the synovial tissue by modulating the proportion of synovial cell subpopulations and regulating the interactions between synovial fibroblasts and macrophages. The innovative nanofiber hydrogel, HAS2@DexP‐Gel, effectively enhances endogenous HA production while reducing synovial inflammation. This comprehensive approach holds promise for improving joint function, alleviating pain, and slowing OA progression, thereby providing significant benefits to patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, The First Affiliated Hospital, Medical 3D Printing Center, Orthopedic Institute, School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu…
- Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, P. R. China.
- Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, P. R. China.
- Department of Orthopaedics, Qilu Hospital of Shandong University, Shandong University Center for Orthopaedics, Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 2500…
- Department of Orthopaedic Surgery, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, Xinjiang, 832099, P. R. China.
ORCID-Profile: Bin Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Gusu Health Talent Project of Suzhou City
- Clinical Medicine Peak Program of Suzhou Medical College of Suzhou University
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Zhou, F., Chen, M., Qian, Y., Yuan, K., Han, X., Wang, W., Guo, J. J., Chen, Q., & Li, B. (2024). Enhancing Endogenous Hyaluronic Acid in Osteoarthritic Joints with an Anti‐Inflammatory Supramolecular Nanofiber Hydrogel Delivering HAS2 Lentivirus. Small. https://doi.org/10.1002/smll.202400542
Vancouver
Zhou F, Chen M, Qian Y, Yuan K, Han X, Wang W, et al. Enhancing Endogenous Hyaluronic Acid in Osteoarthritic Joints with an Anti‐Inflammatory Supramolecular Nanofiber Hydrogel Delivering HAS2 Lentivirus. Small. 2024. doi:10.1002/smll.202400542
BibTeX
@article{Zhou2024,
author = {Zhou, Feng and Chen, Muchao and Qian, Yufan and Yuan, Kai and Han, Xuequan and Wang, Weishan and Guo, Jiong Jiong and Chen, Qian and Li, Bin},
title = {Enhancing Endogenous Hyaluronic Acid in Osteoarthritic Joints with an Anti‐Inflammatory Supramolecular Nanofiber Hydrogel Delivering HAS2 Lentivirus},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202400542}
}
EUVIMED